Protillion Biosciences
Randy Schreckhise is an experienced finance and operations professional with a strong background in the biotechnology and life sciences sectors. Currently serving as the Head of Finance and Operations at Protillion Biosciences, Randy also provides advisory support at The Brink SBDC and holds a board position at the San Diego Entrepreneurs Exchange. As a co-founder of August Therapeutics, Randy focuses on addressing challenges in taste receptor biology related to eating disorders and obesity. Previous roles include Senior Director of Finance at BigHat Biosciences, Vice President of Finance and Operations at Artelo Biosciences, and Chief Operating Officer at Abilita Bio, among others. Randy's educational credentials include an MBA in Finance from Seattle University and a BS in Microbiology and Molecular Biology from Washington State University.
This person is not in any teams
This person is not in any offices
Protillion Biosciences
Protillion Biosciences is a Stanford University spinout commercializing disruptive technology for therapeutic antibody and binder discovery. We have developed an entirely novel, powerful and high-throughput protein display platform designed to revolutionize traditional approaches to the design and development of protein-based drugs.